<?xml version="1.0" encoding="UTF-8"?>
<iati-activities>
 <iati-activity default-currency="CAD" dstore:dataset="idrccrdi-act-2016-6" dstore:index="150" hierarchy="1" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore">
  <iati-identifier>XM-DAC-301-2-109434-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="EN">International Development Research Centre</narrative>
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Rapid, low-cost diagnostics and deployable surge capacity for COVID-19</narrative>
   <narrative xml:lang="FR">Diagnostics rapides et peu co&#xFB;teux et capacit&#xE9; d&#x2019;intensification du d&#xE9;ploiement pour la COVID-19</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Coronaviruses (CoV) are a large family of viruses that cause illnesses ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Common signs of infection include respiratory symptoms, fever, cough, and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. 

The novel coronavirus COVID-19 is a strain that has not been previously associated with humans. The outbreak of COVID-19 highlights the importance of a rapid response to infectious diseases in a highly interconnected world. Innovative diagnostic technologies are key tools in the fight against the spread of COVID-19, allowing frontline responders to quickly triage patients, especially in fragile healthcare systems. This project will develop tools to provide field-ready, low-cost, and deployable surge capacity for the diagnosis and surveillance of COVID-19. Moreover, it aims to foster the ability of teams in Vietnam and Brazil to design and manufacture diagnostic tests.

This project was selected for funding through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, coordinated by the Canadian Institutes of Health Research in partnership with IDRC, the Natural Sciences and Engineering Research Council of Canada, the Social Sciences and Humanities Research Council, and Genome Canada.</narrative>
   <narrative xml:lang="FR">Les coronavirus (CoV) sont une grande famille de virus qui provoquent des maladies allant du simple rhume &#xE0; des maladies plus graves telles que le syndrome respiratoire du Moyen-Orient (MERS-CoV) et le syndrome respiratoire aigu s&#xE9;v&#xE8;re (SRAS-CoV). Les coronavirus sont des zoonoses, c&#x2019;est-&#xE0;-dire que la transmission peut s&#x2019;effectuer entre les animaux et les hommes. Les signes courants d&#x2019;infection comprennent des sympt&#xF4;mes respiratoires, de la fi&#xE8;vre, de la toux et des difficult&#xE9;s respiratoires. Dans les cas les plus graves, l&#x2019;infection peut provoquer une pneumonie, un syndrome respiratoire aigu s&#xE9;v&#xE8;re, une insuffisance r&#xE9;nale, voire la mort. 

Le nouveau coronavirus responsable de la COVID-19 est une souche qui n&#x2019;a jamais &#xE9;t&#xE9; associ&#xE9;e &#xE0; l&#x2019;homme auparavant. L&#x2019;&#xE9;pid&#xE9;mie de COVID-19 nous montre &#xE0; quel point il est important de r&#xE9;agir rapidement aux maladies infectieuses dans un monde aussi interconnect&#xE9; que le n&#xF4;tre. Les technologies de diagnostic innovantes sont des outils essentiels dans la lutte contre la propagation de la COVID-19, car elles permettent aux intervenants de premi&#xE8;re ligne de proc&#xE9;der rapidement au triage des patients, en particulier dans les syst&#xE8;mes de sant&#xE9; fragiles. Ce projet permettra de d&#xE9;velopper des outils offrant une capacit&#xE9; d&#x2019;intensification du d&#xE9;ploiement peu co&#xFB;teuse et facilement utilisable sur le terrain pour le diagnostic et la surveillance de la COVID-19. En outre, il renforcera la capacit&#xE9; des &#xE9;quipes au Vietnam et au Br&#xE9;sil &#xE0; concevoir et &#xE0; fabriquer des tests de d&#xE9;pistage.

Ce projet a &#xE9;t&#xE9; retenu aux fins de financement dans le cadre de la possibilit&#xE9; de financement canadienne pour une intervention de recherche rapide contre la maladie &#xE0; coronavirus 2019 (COVID-19), coordonn&#xE9;e par les Instituts de recherche en sant&#xE9; du Canada en partenariat avec le CRDI, le Conseil de recherches en sciences naturelles et en g&#xE9;nie du Canada, le Conseil de recherches en sciences humaines et G&#xE9;nome Canada.</narrative>
  </description>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">The Governing Council of the University of Toronto</narrative>
  </participating-org>
  <participating-org role="2" type="80">
   <narrative xml:lang="EN">The Governing Council of the University of Toronto</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="EN">Canada. Parliament</narrative>
   <narrative xml:lang="FR">Canada. Parlement</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">International Development Research Centre</narrative>
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-03-05" type="2"></activity-date>
  <activity-date iso-date="2022-03-05" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-country code="BR" percentage="34"></recipient-country>
  <recipient-country code="VN" percentage="33"></recipient-country>
  <recipient-region code="389" percentage="33" vocabulary="1"></recipient-region>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Other</narrative>
   <narrative xml:lang="FR">Autre</narrative>
  </sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="CAD" value-date="2020-09-29">237500</value>
   <provider-org>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Governing Council of the University of Toronto</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="CAD" value-date="2020-03-17">237500</value>
   <provider-org>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Governing Council of the University of Toronto</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="CAD" value-date="2020-03-17">1000000</value>
   <provider-org>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Governing Council of the University of Toronto</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
